États-Unis · Presse financière · Investor's Business Daily

Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher

Publié par Investor's Business Daily · États-Unis il y a 2 h

Rapport Therapeutics stock shot higher Tuesday on promising, but mixed, test results for its bipolar treatment. The post Can This Small Biotech Enter A $4.3 Billion AbbVie Market?…

Lire l'article complet sur Investor's Business Daily Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.investors.com)

Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher

À lire aussi

Google Says Services Are Recovering After U.K. Cloud Outage Hits Businesses

Apple Stock Is the Best Performer in the Mag 7. An Analyst Downgrade Signals It’s Time to Pump the Brakes.

Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher

Partager

À lire aussi

Google Says Services Are Recovering After U.K. Cloud Outage Hits Businesses

Apple Stock Is the Best Performer in the Mag 7. An Analyst Downgrade Signals It’s Time to Pump the Brakes.